Table 1.
Study | Number | Milan criteria | Extended criteria | 5-year survival | |
---|---|---|---|---|---|
Milan | Extended | ||||
Yao et al. [18] | 60 | 46 | 14 | 72% | 72% |
| |||||
Herrero et al. [19] | 61 | 49 | 12 | 79% entire cohort | |
| |||||
Roayaie et al. [20] | 31 | 0 | 31 | N/A | 55% |
| |||||
Kneteman et al. [21] | 40 | 19 | 21 | 4-year survival | |
87% | 83% | ||||
| |||||
Yao et al. [22] | 168 | 130 | 38 | 80% | 82% |
| |||||
Onaca et al. [23] | 1152 | 1038 | 114 | 62% | 54% |
| |||||
Cillo et al. [24] | 100 | 60 | 40 | 3-year survival | |
69% | 85% | ||||
| |||||
Mazzaferro et al. [25] | 1556 | 444 | 1112 | Up-to-seven | |
73.3% | 71.2% | ||||
Exceeding up-to-seven | |||||
73.3% | 53.6% | ||||
| |||||
Guiteau et al. [26] | 445 | 363 | 82 | 72.9% | 70.2% |